此页面上的内容需要较新版本的 Adobe Flash Player。

获取 Adobe Flash Player

 
 

        自20世纪80年代进入中国市场以来,辉瑞一直致力于促进中国经济的发展和提高中国人的健康水平。我们不仅提供丰富的创新产品,并且长期与中国的学术机构以及政府部门等通力合作,支持中国健康事业的快速发展。独特的竞争优势使我们能更好地履行辉瑞中国所肩负的使命:携手共创健康中国!

        Ever since entering the China market in the 1980s, Pfizer has been committed to contributing to both the economic development of China and the health of Chinese citizens. We have been continuously offering a broad innovative product portfolio and actively collaborating with health service providers, academia and governments to support the rapid growth of healthcare in China. Our unique competitive advantages enable us to better realize our mission: Working together for a healthier China.

1980's 20世纪80年代进入中国 Presence in China
1989 在大连建立现代化工厂 Dalian Pharmaceutical Plant
1991 在苏州建立制药厂 Suzhou Pharmaceutical Plant
1995 无锡制药厂/苏州动物保健品厂成立 Wuxi Pharmaceutical Plant /Suzhou Animal Health Plant
1997 在北京成立管理中心 Beijing Management Center
2004 在上海成立中国区总部和辉瑞投资有限公司 Shanghai Regional HQ and Pfizer Investment Co., Ltd.
2005 在上海成立辉瑞中国研发中心 Shanghai China R&D Center
2007 在大连设立辉瑞亚太财务中心 Dalian Pfizer Finance Share Service Center (Asia-Pacific)
2008 苏州营养品厂动工 Suzhou Nutrition Plant
2009 辉瑞并购惠氏,成为中国最大的研发型跨国生物制药公司 Pfizer and Wyeth combine operations
2010 辉瑞亚洲运营中心搬至上海
辉瑞在武汉成立研发中心
Asia Operation Center moves to shanghai
Pfizer R&D center in Wuhan
2011 辉瑞中国直接向美国总部汇报
与海正药业签署合资意向书
Pfizer China reported to Pfizer Corporate directly
Signed the letter of intentwith Hisun Pharmaceutical about setting up a joint venture


未经51job.com同意,不得转载本网站之所有招聘信息及作品;无忧工作网版权所有©1999-2020